A better understanding of the amino acid dependence of CD8+ T cells and the metabolic interplay within the tumor microenvironment will enable us to devise rational and effective approaches to improve T cell metabolic fitness and cancer immunotherapy. This evidence concerns the gene CD8A and neoplasm.